drugset / Trial / NCT04209777

Clinical Evaluation of Smoker Periodontal Subjects After Lactobacillus-reuteri Probiotics and Antibiotics Therapy

NCT04209777

Phase 3 Completed 66 enrolled Dow University of Health Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

It is a clinical trial conducted on smokers with chronic periodontitis in which the participants are divided into two groups and one group is provided with antibiotics while the other with probiotics as an adjunct to non-surgical therapy. The participants were assessed for change in probing pocket depths, attachment loss, bleeding on probing, plaque index and gingival index after 1-month and 3-month period.

Timeline

Start
2018-07-08
Primary completion
2019-04-16
Completion
2019-05-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 500 mg Oral
Subject Lactobacillus reuteri Other / unclassified 2e+08 unknown Oral
Comparator Metronidazole Small molecule 400 mg Oral

Indications